Valuation: Eckert & Ziegler SE

Market Cap 995M 1.14B 914M 852M 1.62B 108B 1.64B 10.98B 4.27B 53.27B 4.27B 4.18B 184B P/E 2026 *
19x
P/E 2027 * 17.6x
Enterprise Value 879M 1.01B 808M 753M 1.43B 95.77B 1.45B 9.7B 3.77B 47.08B 3.78B 3.69B 162B EV / Sales 2026 *
2.73x
EV / Sales 2027 * 2.52x
Free-Float
67.36%
Yield 2026 *
1.23%
Yield 2027 * 1.26%
1 day+1.22%
1 week+3.52%
Current month+2.68%
1 month+2.39%
3 months+8.07%
6 months+4.69%
Current year+3.38%
1 week 15.28
Extreme 15.28
16.1
1 month 14.77
Extreme 14.77
16.1
Current year 13.32
Extreme 13.32
16.82
1 year 13.32
Extreme 13.32
23.03
3 years 9.67
Extreme 9.6667
23.07
5 years 9.67
Extreme 9.6667
46.92
10 years 1.61
Extreme 1.6058
46.92
Manager TitleAgeSince
Chief Executive Officer 59 06/06/2023
Chief Tech/Sci/R&D Officer - 31/12/2024
Chief Operating Officer 59 31/12/2024
Director TitleAgeSince
Chairman 57 06/06/2023
Director/Board Member 66 31/12/2013
Director/Board Member 58 31/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%+3.52% - - 1.14B
-1.95%+1.16%+3.00%-28.72% 16.36B
+5.89%+23.51%+44.56%+95.19% 1.78B
+0.39%+32.34%-39.55%-78.08% 1.24B
+1.31%+4.95%-25.86%-53.39% 640M
+0.21%+3.42%-38.49%-58.09% 582M
-0.66%+3.11%+20.57%-55.49% 447M
+1.79%+0.16%-55.37%-60.09% 382M
+2.52%+7.65%-20.35%-17.75% 362M
-2.14%-1.03%+30.68%+24.68% 329M
Average +0.86%+6.83%-8.98%-25.75% 2.46B
Weighted average by Cap. -0.77%+4.43%+1.41%-23.10%

Financials

2026 *2027 *
Net sales 322M 368M 296M 276M 523M 35.03B 531M 3.55B 1.38B 17.22B 1.38B 1.35B 59.34B 344M 394M 317M 295M 560M 37.52B 568M 3.8B 1.48B 18.44B 1.48B 1.45B 63.55B
Net income 52.28M 59.8M 48.05M 44.78M 84.94M 5.69B 86.23M 577M 224M 2.8B 224M 220M 9.65B 54.93M 62.84M 50.49M 47.06M 89.26M 5.98B 90.61M 606M 236M 2.94B 236M 231M 10.13B
Net Debt -116M -132M -106M -99.05M -188M -12.59B -191M -1.28B -496M -6.19B -496M -486M -21.33B -126M -144M -116M -108M -205M -13.72B -208M -1.39B -540M -6.75B -541M -529M -23.25B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,100
Date Price Change Volume
03/07/26 €15.95 +1.27% 2,084
02/07/26 €15.75 +1.22% 7,266
01/07/26 €15.56 +1.53% 4,835
30/06/26 €15.33 -0.16% 5,427
29/06/26 €15.35 +0.99% 286
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
15.90EUR
Average target price
22.10EUR
Spread / Average Target
+38.99%

Quarterly revenue - Rate of surprise